Torrent Pharmaceuticals Completes Acquisition of JB Chemicals Shares, Now Holds 48.80% Stake
Torrent Pharmaceuticals Limited has completed its acquisition of J.B. Chemicals & Pharmaceuticals Limited shares, acquiring the final 92,490 equity shares (0.06% stake) from a JB Chemicals employee on February 3, 2026. The company now holds 7,83,57,892 equity shares, representing 48.80% of JB Chemicals' equity share capital on a fully diluted basis. All shares under both the primary Share Purchase Agreement dated June 29, 2025, and the employee share purchase agreement dated July 3, 2025, have been successfully acquired, completing the strategic acquisition program.

*this image is generated using AI for illustrative purposes only.
Torrent Pharmaceuticals has successfully completed its strategic acquisition of equity shares in J.B. Chemicals & Pharmaceuticals Limited, marking a significant milestone in the pharmaceutical sector consolidation. The company announced on February 3, 2026, that it has acquired the final tranche of shares under its comprehensive acquisition agreements.
Final Share Acquisition Details
The latest acquisition involved 92,490 equity shares of JB Chemicals, purchased from an employee of the target company. This transaction was executed in accordance with the share purchase agreement dated July 3, 2025, which was specifically designed for acquiring shares from JB Chemicals employees.
| Transaction Details: | Specifications |
|---|---|
| Shares Acquired: | 92,490 equity shares |
| Percentage of Capital: | 0.06% |
| Acquisition Date: | February 3, 2026 |
| Agreement Date: | July 3, 2025 |
| Seller: | JB Chemicals Employee |
Completion of Acquisition Program
Torrent Pharmaceuticals has confirmed that all equity shares targeted under its dual acquisition strategy have been successfully acquired. The acquisition program comprised two main agreements: the primary Share Purchase Agreement dated June 29, 2025, executed between Torrent Pharmaceuticals, Tau Investment Holdings Pte Limited, and JB Chemicals, and the supplementary employee share purchase agreement dated July 3, 2025.
Current Shareholding Position
Following the completion of this acquisition, Torrent Pharmaceuticals' total shareholding in JB Chemicals has reached a substantial position in the pharmaceutical company.
| Shareholding Summary: | Details |
|---|---|
| Total Shares Held: | 7,83,57,892 equity shares |
| Ownership Percentage: | 48.80% |
| Basis: | Fully diluted equity share capital |
| Status: | Acquisition program completed |
Regulatory Compliance and Documentation
The acquisition has been conducted in full compliance with SEBI regulations, specifically under Regulation 30 and Regulation 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Torrent Pharmaceuticals has maintained transparency throughout the acquisition process, with multiple intimations to stock exchanges dating back to June 29, 2025.
The completion of this acquisition represents a strategic expansion for Torrent Pharmaceuticals in the pharmaceutical sector, establishing a significant stake in JB Chemicals & Pharmaceuticals Limited. The systematic approach to the acquisition, involving both institutional and employee shareholdings, demonstrates the company's comprehensive strategy for building substantial positions in target companies.
Historical Stock Returns for Torrent Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.51% | +1.33% | +2.87% | +12.79% | +31.25% | +212.58% |


































